Erratum: A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease [Human Molecular Genetics 22, 5, 2013, 1039-1049] doi:10.1093/hmg/dds492;A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease

Human Molecular Genetics

Volumn 22, Issue 5, 2013, Pages 1039-1049

  Holmans, Peter ^a   Moskvina, Valentina ^a   Jones, Lesley ^a   Sharma, Manu ^d,j   Vedernikov, Alexey ^a   Buchel, Finja ^c   Sadd, Mohamad ^e   Bras, Jose M ^f   Bettella, Francesco ^h   Nicolaou, Nayia ⁱ   Simón sánchez, Javier ⁱ   Mittag, Florian ^c   Gibbs, J Raphael ^b,f   Schulte, Claudia ^d,j   Durr, Alexandra ^k,l   Guerreiro, Rita ^f   Hernandez, Dena ^b,f   Brice, Alexis ^k,l,m   Stefánsson, Hreinn ^h   Majamaa, Kari ⁿ   Gasser, Thomas ^d,j   Heutink, Peter ⁱ   Wood, Nicholas W ^f,g   Martinez, Maria ^e   Singleton, Andrew B ^b   Nalls, Michael A ^b   Hardy, John ^f   Morris, Huw R ^a   Williams, Nigel M ^a   more..

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h DECODE GENETICS   (Iceland)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^k INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^l SORBONNE UNIVERSITÉ   (France)

^m ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

ⁿ UNIVERSITY OF OULU   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA ANTIGEN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; HEREDITY; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MULTICENTER STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84873486299     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt554     Document Type: Erratum

References (47)

1. Nussbaum, R.L. and Ellis, C.E. (2003) Alzheimer's disease and Parkinson's disease. N. Engl. J. Med., 348, 1356-1364.
2. Wickremaratchi, M.M., Ben-Shlomo, Y. and Morris, H.R. (2009) The effect of onset age on the clinical features of Parkinson's disease. Eur. J. Neurol., 16, 450-456.
3. Van Den Eeden, S.K., Tanner, C.M., Bernstein, A.L., Fross, R.D., Leimpeter, A., Bloch, D.A. and Nelson, L.M. (2003) Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol., 157, 1015-1022.
4. Gilks, W.P., Abou-Sleiman, P.M., Gandhi, S., Jain, S., Singleton, A., Lees, A.J., Shaw, K., Bhatia, K.P., Bonifati, V., Quinn, N.P. et al. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet, 365, 415-416.
5. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
6. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
7. Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C.J., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256-259.
8. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M.K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
9. Nalls, M.A., Plagnol, V., Hernandez, D.G., Sharma, M., Sheerin, U.-M., Saad, M., Simón-Sánchez, J., Schulte, C., Lesage, S., Sveinbjörnsdóttir, S. et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 377, 641-649.
10. International Parkinson's Disease Genomics Consortium and Wellcome Trust Case Control Consortium (2011) A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet., 7, e1002142.
11. Hamza, T.H., Zabetian, C.P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D.M., Doheny, K.F., Paschall, J., Pugh, E. et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet., 42, 781-785.
12. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A. et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet., 41, 1303-1307.
13. Pankratz, N., Wilk, J.B., Latourelle, J.C., DeStefano, A.L., Halter, C., Pugh, E.W., Doheny, K.F., Gusella, J.F., Nichols, W.C., Foroud, T. et al. (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum. Genet., 124, 593-605.
14. Edwards, T.L., Scott, W.K., Almonte, C., Burt, A., Powell, E.H., Beecham, G.W., Wang, L., Züchner, S., Konidari, I., Wang, G. et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet., 74, 97-109.
15. Fung, H.C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J.R., Langefeld, C., Stiegert, M.L., Schymick, J. et al. (2006) Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol., 5, 911-916.
16. Maraganore, D.M., de Andrade, M., Lesnick, T.G., Strain, K.J., Farrer, M.J., Rocca, W.A., Pant, P.V.K., Frazer, K.A., Cox, D.R. and Ballinger, D.G. (2005) High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet., 77, 685-693.
17. Spencer, C.C., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Band, G., Barker, R., Bellenguez, C., Bhatia, K., Blackburn, H. et al. (2011) Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum. Mol. Genet., 20, 345-353.
18. Simón-Sánchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S.W., Hernandez, D.G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet., 41, 1308-1312.
19. Simón-Sánchez, J., van Hilten, J.J., van de Warrenburg, B., Post, B., Berendse, H.W., Arepalli, S., Hernandez, D.G., de Bie, R.M.A., Velseboer, D., Scheffer, H. et al. (2011) Genome-wide association study confirms extant PD risk loci among the Dutch. Eur. J. Hum. Genet., 19, 655-661.
20. Keller, M., Saad, M., Bras, J.M., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buechel, F., Sharma, M., Gibbs, J.R. et al. (2012) Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Hum. Mol. Genet., 21, 4996-5009.
21. Park, J., Lee, S.B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature, 441, 1157-1161.
22. Kamp, F., Exner, N., Lutz, A.K., Wender, N., Hegermann, J., Brunner, B., Nuscher, B., Bartels, T., Giese, A., Beyer, K. et al. (2010) Inhibition of mitochondrial fusion by a-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J., 29, 3571-3589.
23. Thomas, K.J., McCoy, M.K., Blackinton, J., Beilina, A., van der Brug, M., Sandebring, A., Miller, D., Maric, D., Cedazo-Minguez, A. and Cookson, M.R. (2011) DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum. Mol. Genet., 20, 40-50.
24. Cremades, N., Cohen, S.I.A., Deas, E., Abramov, A.Y., Chen, A.Y., Orte, A., Sandal, M., Clarke, R.W., Dunne, P., Aprile, F.A. et al. (2012) Direct observation of the interconversion of normal and toxic forms of a-synuclein. Cell, 149, 1048-1059.
25. Sha, D., Chin, L.S. and Li, L. (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum. Mol. Genet., 19, 352-363.
26. Xiong, H., Wang, D., Chen, L., Choo, Y.S., Ma, H., Tang, C., Xia, K., Jiang, W., Ronai, Z., Zhuang, X. et al. (2009) Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest., 119, 650-660.
27. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 25, 302-305.
28. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA, 97, 13354-13359.
29. Baranzini, S.E., Galwey, N.W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B.M.J., Kappos, L., Polman, C.H. et al. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet., 18, 2078-2090.
30. Ritchie, M.D. (2009) Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis. Genome Med., 1, 65.
31. Wang, K., Li, M. and Bucan, M. (2007) Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet., 81, 1278-1283.
32. Holmans, P., Green, E.K., Pahwa, J.S., Ferreira, M.A.R., Purcell, S.M., Sklar, P., Owen, M.J., O'Donovan, M.C. and Craddock, N. (2009) Gene Ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet., 85, 13-24.
33. Jones, L., Holmans, P., Hamshere, M.L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R. et al. (2010) Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One, 5, e13950.
34. Lesnick, T.G., Papapetropoulos, S., Mash, D.C., Ffrench-Mullen, J., Shehadeh, L., de Andrade, M., Henley, J.R., Rocca, W.A., Ahlskog, J.E. and Maraganore, D.M. (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet., 3, e98.
35. Srinivasan, B.S., Doostzadeh, J., Absalan, F., Mohandessi, S., Jalili, R., Bigdeli, S., Wang, J., Mahadevan, J., Lee, C.L.G., Davis, R.W. et al. (2009) Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease. Hum. Mut., 30, 228-238.
36. Stone, D.K., Reynolds, A.D., Mosley, R.L. and Gendelman, H.E. (2009) Innate and adaptive immunity for the pathobiology of Parkinson's disease. Antioxid. Redox Signal., 11, 2151-2166.
37. Brochard, V., Combadie're, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.M. et al. (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest., 119, 182-192.
38. Castellani, R.J., Nugent, S.L., Morrison, A.L., Zhu, X., Lee, H.G., Harris, P.L.R., Bajić, V., Sharma, H.S., Chen, S.G., Oettgen, P. et al. (2011) CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease. J. Neural Transm., 118, 23-26.
39. Mogi, M., Kondo, T., Mizuno, Y. and Nagatsu, T. (2007) p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci. Lett., 414, 94-97.
40. Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M. and Onofrj, M. (2009) Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun., 23, 55-63.
41. Kubo, M., Kamiya, Y., Nagashima, R., Maekawa, T., Eshima, K., Azuma, S., Ohta, E. and Obata, F. (2010) LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation. J. Neuroimmunol., 229, 123-128.
42. Saad, M., Lesage, S., Saint-Pierre, A., Corvol, J.C., Zelenika, D., Lambert, J.C., Vidailhet, M., Mellick, G.D., Lohmann, E., Durif, F. et al. (2011) Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum. Mol. Genet., 20, 615-627.
43. Moskvina, V. and Schmidt, K.M. (2008) On multiple-testing correction in genome-wide association studies. Genet. Epidemiol., 32, 567-573.
44. Harris, M.A., Clark, J., Ireland, A., Lomax, J., Ashburner, M., Foulger, R., Eilbeck, K., Lewis, S., Marshall, B., Mungall, C. et al. (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res., 32, D258-D261.
45. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. and Tanabe, M. (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res., 40, D109-D114.
46. Bult, C.J., Eppig, J.T., Kadin, J.A., Richardson, J.E. and Blake, J.A. (2008) The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Res., 36, D724-D728.
47. Simes, R. (1986) An improved Bonferroni-type procedure for multiple tests of significance. Biometrika, 73, 751-754.